Article

NFYA promotes the malignant behavior of triple-negative breast cancer through the…

medRxiv · 2022 · Nobuhiro Okada

Key facts

Title NFYA promotes the malignant behavior of triple-negative breast cancer through the regulation of lipid metabolism
First author Nobuhiro Okada
Journal medRxiv
Published May 28, 2022
DOI 10.1101/2022.05.26.493660
Product codes mentioned LXG

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature